Skip to main content
. 2021 Jun;9(12):1033. doi: 10.21037/atm-20-8124

Table 2. Autoimmune disease frequency identified who received ICI therapy.

Autoimmune disease Frequency (n=42)
Rheumatologic 17 (40%)
   1. Rheumatoid arthritis 5
   2. Polymyalgia rheumatica 5
   3. Psoriatic arthritis 4
   4. Inflammatory arthritis 1
   5. Scleroderma 1
   6. Henoch Schönlein purpura 1
Dermatologic 10 (24%)
   1. Psoriasis 6
   2. Cutaneous lupus 2
   3. Vitiligo 1
   4. Bullous pemphigoid 1
Endocrine 4 (10%)
   1. Hashimoto’s thyroiditis 1
   2. Graves disease 1
   3. Autoimmune hypophysitis 1
   4. Type 1 diabetes mellitus 1
Gastrointestinal 2 (5%)
   1. Crohn’s 1
   2. Ulcerative colitis 1
Neurologic 5 (12%)
   1. Guillain Barre 2
   2. Myasthenia gravis 1
   3. Multiple sclerosis 1
   4. Chronic inflammatory demyelinating neuropathy 1
Others 4 (10%)
   1. Immune thrombocytopenic purpura (ITP) 2
   2. Pulmonary sarcoidosis 1
   3. Membranoproliferative glomerulonephritis (MPGN) 1